Analysis Of Relationship Between Consumer Behavior And Effectiveness Of Heart Medicines

Nowadays many research dealing with the food consumer behavior and its relationship with health status of population, thus the demand of pharmaceutical market. It is well known that cardiovascular diseases such as ischaemic heart diseases are the most common cause of the early and suddenly mortality. The higher level of pharmaceutical preventive technologies may result partly that fewer people need to consume heart medicines due to the healthy diet, on the other hand that the therapies can keep low the heart mortality rate inside of all mortality. Effectiveness of medicine treating heart diseases is not same in the examined OECD countries, which can also be traced back to different food consumption due to the same forms of treatment and the risks of the disease between regions. The examined OECD countries were selected based on consumer data availability. The target of analysis is to research the relationship between the „ineffectiveness” of heart medicine consumption (via the heart mortality data) and the health awareness in food consumption that also shows the subjective utility of preventive health services. During the examination of preventive services market it could be consider only costumer decisions those motivate effort to realize and maximize health utility that can obtain by reducing the objective likelihood of later illness (prevention defined by the reduction of influenced risk factors). For this it has to be eliminated the impact of all factors in consumption those are not associated with health consciousness – calculation of price and income flexibility serve it. Every nutritional culture considered unhealthy or incorrect, which exceeds the critical values expressed in dietetics recommendations. The data described in a 2 dimensional diagrams, and between diagrams the distances from reference country data to data of another country examine with correlation coefficient. It can conclude there is a strongest connection between the carbohydrate/fat consumer rates and the effect of medical treatments than between the latter and fat or fat/protein consumer rates. Basically, my research is empirical and quantitative.